In contrast, the concentrations of MMP-3 (Goncalves et al. 2015) and the adipose tissue derived anti-inflammatory cytokine adiponectin (APN), which can increase the expression of MMP-3 (Tong et al. 2011), are reduced in patients with T2D. Here, MMP3 is linked to type 2 diabetes mellitus.